| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,280 | $30 | $213.3K |
| J0897 | Injection, denosumab, 1 mg | 6,180 | $20 | $111.2K |
| J3262 | Injection, tocilizumab, 1 mg | 21,640 | $10 | $108.2K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,370 | $30 | $68.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,530 | $20 | $58.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,650 | $10 | $56.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 460 | $90 | $43.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $110 | $33K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 280 | $70 | $18.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 140 | $60 | $8.3K |